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Obesity is currently described as one of our
major health problems [1]. The yearly costs of so-
matic complications due to obesity are estimated
to be 8% of the total health costs in industrialized
countries [2]. The distinct increase in the pre-
valence of obesity among adults, up to 35% in the
USA and 28% for overweight and 6.8% for obese
subjects in Switzerland [3], runs parallel to an in-
crease in overweight children in all industrial
countries [4]. According to the fact that in the last
10 to 15 years the prevalence of obesity in children
in Europe and the USA has doubled [5, 6], it is ex-
pected that the prevalence of overweight and obese
people will increase further during the next com-
ing years. Obesity is closely associated with vari-
ous chronic disorders such as cardiovascular dis-
eases, metabolic syndrome and mental disorders
(e.g. anxiety and mood disorders [7]). Prevention
and treatment of these co-morbid disorders repre-
sent a considerable workload for the health system.
Definition and symptoms from a biological,
psychological and sociological view 
Nowadays aetiology and maintenance of
obesity is discussed as a combination of biological,
psychological and sociological factors. Defining
obesity is straightforward: an excess of body fat.
Obesity has to be distinguished from overweight,
which refers to weight in excess of some standard.
In contrast to clinical studies in which obesity is
often defined on the basis of direct measures of
obesity (e.g. using underwater weighing, com-
In order to evaluate the effectiveness of a cog-
nitive behavioural group therapy programme for
the treatment of obesity in clinical practice, 122
patients from 14 general practices (n = 70) were
randomised into either a treatment or a control
arm with a ratio of 3 to 2. The group treatment
programme was also assessed in a clinical centre 
(n = 52; University Hospital Basel). Before therapy,
a clinical interview and a mental disorder exami-
nation were carried out on all patients.
The instructors of the programme (practi-
tioners; clinic physicians) were trained during two
afternoon meetings to supervise the group ses-
sions. The treatment programme consisted of 16
group sessions of 90 min each, and contained psy-
cho-educational elements concerning a balanced
diet, instruction for the integration of more activ-
ity in everyday life (lifestyle activity), problem-
solving strategies, and the cognitive restructuring
of dysfunctional cognition regarding the own
body.
All the patients who were treated in the vari-
ous settings demonstrated a benefit from therapy.
Compared to the control groups which received
usual medical care, they were able to reduce their
starting weight by around 5% (p <0.001 for the
group treated by practitioners) at the end of treat-
ment and stabilise it until follow up after one year.
In regard to psychological factors the treatment
groups showed an increased sense of control over
eating behaviour, and feelings of distractibility and
hunger were reduced after treatment and at follow
up (p <0.05). All treatment groups showed statisti-
cally relevant increases in feelings of attractiveness
regarding their body and shape (p <0.05). These
results support the effectiveness of the integrated
cognitive behavioural treatment programme in
clinical practice over a duration of 12 months.
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puted tomography); in large-scale, population-
based surveys obesity is most often defined on the
basis of weight and height. Height and weight data
can be expressed in terms of the body mass index
(BMI = weight in kilograms per height in meters2).
Overweight is defined as a BMI of 25–29.9 kg/m2
and obesity as ≥30 kg/m2 [8].
Obesity is currently regarded as a chronic and
recurring disorder [9]. The aim of treatment is the
handling of the vulnerability factors, striving for a
long-term, moderate weight reduction.
Besides the wide number of medical compli-
cations which lead to increased morbidity and
mortality, obesity is associated with labelling and
negative consequences in psychosocial areas, e.g.
with lower working positions despite an equal
qualification, or with fewer long-term personal
relationships [10, 11]. 
Allocation of blame and stigmatisation con-
tribute to the person focusing on the negative
aspects of body and self, and, due to their wish to
loose weight and in order to fit in with the social
“norm”, they often develop a rigid and restrictive
eating behaviour and a negative body and self con-
cept [6, 12, 13]. The often experienced “weight-
cycling” leads to further weight gain. Related to
the experience of loss of control during diet efforts,
the risk of developing eating disorders, especially
a Binge Eating Disorder (BED), is increased fur-
ther [14–17]. As a result, general self-efficacy de-
creases, resulting in increased resignation and iso-
lation [18]. The negative assessment of self-effi-
cacy can generalize to other problems and promote
affective disorders.
Current treatment of obesity emphasizes an
individualized and multimodal approach based on
diet, exercise and behavioural changes. Regular
physical activity is a key component, especially for
the maintenance of weight loss [12]. The effect of
exercise is more often evident as long-term weight
loss than after the initial stages of weight loss pro-
grammes. There is no longer any doubt that the
likelihood of long-term weight loss during an
integrative weight loss programme is enhanced in
individuals exercising regularly. Low-level activity
if done regularly is likely to have beneficial effects
and may produce better adherence than more
strenuous exercise prescriptions.
Therapeutic interventions
Table 1 shows the commonly known effective
factors in the treatment of obesity, i.e. its treatment
aims and the corresponding interventions, which
were included in the programme “BASEL” (which
stands for: “Behandlungsprogramm der Adipositas
mit den Schwerpunkten Essverhalten- und
Lebensstiländerung”, or: “Treatment programme
for obesity with main emphasis on eating behav-
iour and life style changes”).
As opposed to well-known “crash diets” which
demonstrate a high risk of weight regain (weight
cycling), the concept of a long term change of nu-
tritional, eating and exercise habits is the most
promising approach [9, 19, 20].
Evaluation of individual treatment concepts is
difficult because the various studies differ regard-
ing measurements of success and because of lack of
long-term follow-up [9, 21, 22]. Furthermore, in
most studies neither the treatment modules nor
the qualification type of the treatment persons
were described. The results from the studies re-
viewed above paint a pessimistic picture, as most
of the patients regained their lost weight within the
observation period (mainly up to 1 year) [12].
Objective of the present investigation
The aim of the present investigation was to
evaluate a treatment programme for obesity with
the main focus on changing nutrition and life-style
(BASEL), adapted from the programme LEARN,
[23] in clinical practice.
Motivation-support Nutritional behaviour Eating habits Physical activity Social skills Body image
Aims of Development of long- Long-term changeover Reduction of Changing the passive Reduction of Changing the negative 
treatment term motivation and to a balanced, fat- rigid control, lifestyle, stepwise, isolation and retreat, body image 
compliance reduced nutrition development of long-term increase development of 
flexible control in daily activity, social skills 
sport
Inter- Psycho-education Psycho-education, Psycho-education, Psycho-education, Psycho-education, Psycho-education,
vention setting realistic aims self-observation, self-observation increasing and practicing social self-observation,
for: weight, nutrition, gradual substitution practising more maintaining competence body image exercises
eating habits and of fat and calorie-rich flexible control motivation and self-confidence,
increasing activity food with a more problem-solving 
balanced nutrition training
Table 1
Therapeutic interventions.
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Subjects and procedures
The sample consisted of patients from the clinical
centre, patients from general practices as well as patients
who replied to newspaper advertisements. Severe mental
disorders (major depression, schizophrenia) as well as in-
sulin-dependent diabetes, hypothyroidism or terminal
diseases were excluded. Inclusion criterion was the pres-
ence of obesity (BMI ≥30 kg/m2); a physical examination
was performed by a physician. There was a total of 122 pa-
tients (30 males and 92 females) with an average age of
45.2 years (SD: 23.9). Patients from general practices (n =
70) were randomised into either treatment (GP BASEL)
or control (GP control) groups with a ratio of 3 to 2. Sub-
jects (n = 52) in the clinical centre (treatment groups were
named Clinic BASEL) were treated by an interdisciplinary
team consisting of a trained physician, a psychologist and
a dietician. Table 2 shows the baseline characteristics of
the sample.
There were no differences between the three study
groups (Clinic BASEL, GP BASEL, GP control) of sub-
jects regarding sociodemographic variables, with the ex-
ception of the BMI. The BMI of the group treated in the
clinical centre (Clinic BASEL) was significantly higher
than that of the control group treated by practitioners (GP
control; U = 17.000, p <0.01).
Treatment programme
The group treatment consisted of a total of 16 ses-
sions of 90 min each, standardised according to the ther-
apy concept of the BASEL programme. The treatment
took place at either the clinical centre or in the general
practice; there were a total of 18 treatment groups.
In the first group-session the patients were presented
with the standardised manual-based procedure. The
programme aimed at long-term, stepwise alterations of
lifestyle, i.e. of nutrition, eating behaviour, physical activ-
ity, social competence and body image. Table 3 shows the
contents of each session. During the treatment there was
no medical intervention and the patients did not take part
in any other weight-reducing programme.
The practitioners and the tutors in the clinic were
trained by a psychologist and by a dietician with a struc-
tured training course lasting 2 times 4 hours to supervise
the behavioural weight loss program groups. In addition,
the practitioners and the tutors had supervision sessions
every month with a psychologist. The GP control group
was mainly observed; it received non-specific comments
about general measures to lose weight. No specific tech-
nique, tools or written material was used. 
Method
Group Gender Age Body Mass Index First manifestation 
F = Females (yrs) (kg/m2) of obesity
M = Males (n) (age, yrs)
F M F M F M F M
GP BASEL 42 11 49 ± 12 45 ± 14 35.7 ± 5.6 36.8 ± 5.2 32 ± 14 36 ± 6
GP control 10 7 49 ± 10 49 ± 10 34.0 ± 3.0 33.4 ± 2.5 29 ± 12 28 ± 6
Clinic BASEL 40 12 46 ± 13 37 ± 13 38.3 ± 7.1 40.0 ± 8.2 25 ± 13 20 ± 12
Data are means ± SD.
Table 2
Baseline data 
of the subjects.
Session Treatment 
No.
1 Clarification and enhancing of motivation
Realistic weight aims
Information about the manual-based treatment
2 Information about the development and maintenance of obesity
Self-observation of eating behaviour and nutrition
Monitoring sheets
3 Start of continuous informations about a balanced nutrition
4 Recognising rigid examples of eating behaviour, dieting behaviour and introduction 
of the ABC-model*
5 Learning of strategies for more flexible control of eating behaviour
6 Learning of strategies concerning eating and nutritional habits and their transfer into daily life
7 Alteration of eating and nutritional behaviour: aim-analysis and application of strategies
8 Self-observation and problem analysis concerning physical activity
9 Aim-analysis and acquisition of strategies for increasing physical activity in everyday life
10 Psychoeducation for dealing with the own body, body image and changing the negative 
body image
11 Stepwise increase of physical activity, information about suitable types of sport
12 Recognition and alteration of dysfunctional cognitions regarding effectiveness in problem solving
13 Recognition and alteration of dysfunctional cognitions
14 Information and acquisition of strategies for improvements in social competence
15 Relapse prevention: recognition of risk situations, acquisition of strategies for dealing
with difficult situations
16 Conclusion and final take home messages
* A = Antecedents; B = Behaviour; C = Consequences (reiterative process of behaviour modification)
Table 3
Contents of
programme BASEL.
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Instruments
During the investigation the BMI (kg/m2) was
recorded at the start, end and 12 months after completion
of treatment. The eating behaviour was assessed using a
self report questionnaire “Fragebogen zum Essverhalten”,
FEV (24, German version of the Three-factor Eating
Questionnaire, 25). General psychopathological symp-
toms were recorded according to the revised Symptom
Check List [26], the subjective judgment of the body using
a body image questionnaire (FbeK), [27], and quality of
life was assessed with a questionnaire for life-satisfaction
(Fragebogen zur Lebenszufriedenheit, FLZ) [28]. Data
collection was carried out at the beginning of treatment,
on completion and 12 months later (1 year follow-up).
Dropout rates
The dropout rate until the end treatment was 23%,
29% and 37% in the GP BASEL, the GP control and in
the Clinic BASEL groups, respectively. This resulted in a
distorted ratio between BASEL treated and control sub-
jects (ratio: almost 3:1; aimed ratio: 3:2).
The dropout rate between the end of treatment and
the 1–year follow up was 0%, 33% and 52% in the GP
BASEL, the GP control and in the Clinic BASEL groups,
respectively.
Thus, there was a high dropout rate in all groups; the
rate was particularly high in the Clinic BASEL group. Due
to disparate sample sizes only the comparison between the
GP BASEL group and the Clinic BASEL group at the
time of the 1–year-follow up reached statistical signifi-
cance (p <0.01).
Statistical analyses
Wilcoxon- and U-tests were run to compare the dif-
ferent samples concerning the dependent variables at the
beginning, the end and one year after the start of treat-
ment.
During treatment there were varying levels of
dropouts which reduced data, and a further reduction in
the data base is due to limited follow up.
Results
There was a trend towards weight loss in both
treatment groups over the three time-points of as-
sessment (see Table 4). Patients in the treatment
groups in the GP BASEL setting show a signi-
ficantly lower weight at the end of treatment (p
<0.001) and differ significantly from GP control
group at 1–year follow up. The GP BASEL group
reached a higher percentage of weight change than
the GP control group (4.7% vs. 0.5%; p <0.05).
Psychological variables
Eating behaviour
Group means, standard deviations and the
course over time of the three scales of the FEV
(cognitive control, distractibility, feelings of
hunger) within the particular groups are shown in
Table 5.
Cognitive control increased significantly in
both treatment conditions (GP BASEL setting and
Clinic BASEL) over the time course. One year
after the end of treatment cognitive control was
still significantly stronger and distinctive than at
the start of the therapy (p <0.001 and p <0.01, re-
spectively). At the end of treatment the cognitive
control of the patients in the GP BASEL setting
differed significantly from the one in the GP con-
trol condition (p <0.05). The variable distractibil-
ity decreased over time in all three study groups.
But only in the GP BASEL setting and the Clinic
BASEL group did the reduction at treatment end
reach a significant level (p <0.001 and p <0.05,
respectively). There was a significant decrease of
distractibility (eating triggered by emotional or
situational cues) (p <0.001) between beginning of
Variable Start of therapy End of therapy 1 year Follow-up
(after 16 sessions)
Mean SD Mean SD p-value Mean SD p-value p-value
T1/T2 T2/T3 T1/T3
BMI (kg/m2)
GP BASEL 36.2 6.5 34.8 6.6 *** 34.4 6.8 n.s. ***
GP control 32.6 1.8 32.3 2.0 n.s. 32.4 2.7 n.s. n.s.
Clinic BASEL 38.5 7.5 38.0 7.8 n.s. 37.6 6.4 n.s. n.s.
Weight (kg) n.s. n.s. n.s.
GP BASEL 96.8 17.1 93.0 17.6 *** 92.1 18.2 n.s. ***
GP control 86.3 6.4 85.6 6.8 n.s. 85.9 9.2 n.s. n.s.
Clinic BASEL 106.8 26.1 105.2 26.1 n.s. 103.9 21.8 n.s. n.s.
Percent change of body weight
GP BASEL –4% –4.7%
GP control –0.7% –0.5%
Clinic BASEL –1.6% –2.9%
Notes: T1 = beginning, T2 = end of treatment; T3 = 1 yr follow-up.
The p values refer to pairwise U-tests within groups. ***p <0.001; n.s.: not significant.
Table 4
BMI, body weight
and percent change
of body weight.
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therapy and 1-year follow up. Feelings of hunger
decreased from the start of treatment until the end
of therapy in the GP BASEL and the Clinic
BASEL setting (p <0.001and p <0.01, respec-
tively). One year after the end of treatment there
was still a further significant decrease of feelings 
of hunger for both treatment groups (p <0.001 and
p <0.01, respectively). 
Body image
Group mean values, standard deviations and
course over time of the four scales of the FBeK
(attractiveness, accentuation of one’s own body,
insecurity, and physical misperception) within the
particular groups are shown in Table 6.
The extent of self evaluation of attractiveness
(scale attractiveness) increased in both treatment
conditions during therapy (p <0.01 for GP BASEL
and p <0.05 for Clinic BASEL, respectively) and
Scale Start of treatment End of treatment 1 year Follow-up
(Score) (Score) (Score)
Mean SD Mean SD p-value Mean SD p-value p-value
T1/T2 T2/T3 T1/T3
Cognitive control
GP BASEL 8.7 4.4 14.7 4.3 *** 13.9 4.7 * ***
GP control 9.0 2.8 10.4 4.6 n.s. 9.6 5.2 n.s. n.s.
Clinic BASEL 9.1 4.3 15.0 2.4 *** 14.7 4.0 n.s. **
Distractibility
GP BASEL 9.4 3.7 6.3 4.1 *** 6.8 4.0 * ***
GP control 9.9 3.0 8.7 4.0 n.s. 8.4 4.2 n.s. n.s.
Clinic BASEL 8.8 4.6 6.6 4.2 * 7.3 4.1 n.s. *
Feelings of hunger
GP BASEL 6.4 3.4 4.0 3.5 *** 4.4 3.9 n.s. ***
GP control 6.9 3.5 5.4 4.2 n.s. 6.0 4.6 n.s. n.s.
Clinic BASEL 6.5 4.2 3.7 4.1 ** 3.6 4.1 n.s. **
Notes: The p-values refer to pairwise U-tests within groups. * p <0.05; ** p <0.01*; *** p <0.001; n.s.: not significant.
Cognitive control: a higher score represents more restrained eating;
Distractibility: a higher score represents more frequently provoked eating by emotional or situational conditions;
Feelings of hunger: a higher score represents a stronger feeling of hunger.
Table 5
Questionnaires 
of eating behaviour
(FEV; QEB).
Scale Start of treatment End of treatment 1 year-Follow-up
(Score) (Score) (Score)
Mean SD Mean SD p-value Mean SD p-value p-value
T1/T2 T2/T3 T1/T3
Attractiveness/ self-confidence
GP BASEL 7.0 3.7 8.6 3.9 ** 8.6 3.8 n.s *
GP control 6.0 5.2 6.7 6.0 n.s. 5.2 6.5 n.s n.s
Clinic BASEL 5.2 2.6 8.4 4.7 * 8.1 4.1 n.s *
Accentuation of appearance
GP BASEL 6.7 2.2 6.7 2.7 n.s 6.6 2.5 n.s n.s
GP control 5.8 2.5 6.5 2.2 n.s 6.0 1.7 n.s n.s
Clinic BASEL 6.2 3.1 6.4 2.7 n.s 6.7 2.1 n.s n.s
Insecurity/concern
GP BASEL 4.8 1.9 4.2 2.8 n.s 3.7 2.0 n.s ***
GP control 5.8 4.0 6.8 3.3 n.s 5.7 3.9 n.s n.s
Clinic BASEL 4.8 3.2 5.0 3.5 n.s 4.8 3.3 n.s n.s
Physical/sexual misperception
GP BASEL 2.0 1.4 1.7 1.6 n.s 1.7 1.5 n.s n.s
GP control 3.7 1.8 3.7 1.2 n.s 3.8 2.5 n.s n.s
Clinic BASEL 1.4 1.5 2.1 1.8 n.s 1.3 1.9 n.s n.s
Notes: The p-values refer to the pairwise U-tests within groups; * p <0.05; ** p <0.01*; *** p <0.001; n.s.: not significant.
Attractiveness/self confidence: a higher score represents an accepting attitude to the own body;
Accentuation of appearance: a higher score represents a conscious and confident dealing with the own appearance;
Insecurity/Concern: a higher score represents focussing on negative aspects of the body and feelings of insecurity;
Physical/sexual misperception: a higher score represents more physical/sexual misper-ceptions.
Table 6
Questionnaires 
of body image 
(FBeK; QOB).
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was still significantly stronger and distinctive one
year after the end of the treatment than at the be-
ginning of treatment (p <0.05 for GP BASEL and
Clinic BASEL). There were no significant changes
in the GP control group. The insecurity and con-
cern considering one’s body decreased signifi-
cantly only in the GP BASEL setting from the first
assessment to the one-year-follow-up (p <0.001).
The groups differed – but not significantly – in the
scale of physically-sexual misperception by the fact
that the control group expressed a stronger mis-
perception than the two treatment groups at all of
the three measurements.
Psychopathological symptoms
The scale “depression” of the revised Symp-
tom-Check-List (SCL-90) demonstrated a de-
creasing trend for the patients in the GP BASEL
group. Anxiety decreased, trendwise, in both the
GP BASEL and in the Clinic BASEL settings.
There were no further significant changes over
time and between treatment groups.
Discussion
The aim of the present study was to evaluate
the treatment programme BASEL for clinical
practice. The standardised cognitive-behavioural
treatment concept was applied to patients in gen-
eral practices (GP BASEL group) and in a clinical
centre (Clinic BASEL group) setting. A group of
patients in general practice treated using no spe-
cific weight loss methods served as a waiting con-
trol group (GP control group). The manual-based
treatment turned out to be effective in the GP
BASEL setting in a short-term perspective and
after one year. The 4.7% weight loss observed dur-
ing therapy represents a modest but significant
health improvement [29, 30]. A weight loss of
5–10% can successfully reduce the co-morbid con-
ditions associated with obesity such as dyslipid-
aemia, hypertension and diabetes [31].
Regarding the subjects treated in a specialised
clinical institution, there was also a reduction of
body weight, but it did not reach statistical signif-
icance. 
In addition, the results of the present study
demonstrated that the patients of the two treat-
ment groups learned to control their eating be-
haviour in a flexible way. The increase in cognitive
control over eating behaviour represents an
achievable goal, indicating a long term (1 year)
success [32].
The reduction of distractibility during eating
implicates a better coping with triggers (e.g. emo-
tions, external factors such as viewing or smelling
of food) of uncontrolled eating behaviour. It would
be interesting for future studies to investigate,
whether this decrease in distractibility was associ-
ated with the literally mentioned change in nutri-
tional habits (carbohydrate-rich and fat-poor nu-
trition, [33]. Overall, these changes in eating be-
haviour point to an increase in self-control of eat-
ing behaviour by internal factors such as hunger or
satiety.
Regarding body image, treatment with the
programme resulted in a more accepting attitude
concerning one’s own body and appearance. This
result is especially relevant because it can be as-
sumed that concerning only moderate weight loss,
the better acceptance of the own body represents
a restructuring of dysfunctional cognitions which
is not to be attributed to a visible change of shape.
A better acceptance of the own body turns out to
be an achievable goal in the treatment of obesity,
because it is shown in the literature that a negative
body image leads to more distress, a negative self-
concept, isolation, and can be a relevant trigger of
uncontrollable eating behaviour. Further, it has
been shown that acceptance of the own body rep-
resents a predictor of long term weight loss [6, 34,
35].
There were no significant changes concerning
psychopathological symptoms over the treatment
course and at 1-year follow up. While the two
treatment groups showed a trend of decreased feel-
ings of depression in the GP BASEL group and
anxiety in the Clinic BASEL group, the control
group suffered from even more symptoms during
the time of the investigation. Considering the fact
that especially mood and anxiety disorders are
widely spread in obese patients [35–37] further
treatment programmes should take the prevention
and treatment of these symptoms into account.
There are several limitations to the study war-
ranting consideration. First, there was no ran-
domisation of the participants into the two treat-
ment settings. It can not be excluded therefore that
differences between the patient groups might have
influenced the results. For example we found a
high percentage of co-morbid mental disorders
(assessed by structured clinical interviews) in the
sample of the specialised institution. For reasons
of practicability these clinical interviews could not
be carried through in the GP BASEL and the GP
control group. Further, our results are limited by
the fact that we had a high dropout rate compared
to the literature. The dropout rates were even dif-
ferent in several samples. The lower dropout rate
in the groups treated by practitioners suggests that
the latter had a more intense patient-doctor rela-
tionship. It also has to be investigated whether
there were differences in patients characteristics
(especially concerning point prevalence of mental
disorders) between clinical and nonclinical sam-
ples which influenced dropout rates and treatment
outcome. Further studies should assess the reasons
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why patients dropped out and what they did after
dropping out of the treatment procedure.
It also remains open whether an equal or
similar effect could be reached by reducing the
treatment frequency [38].
Finally a standardised follow-up should be
carried out and be evaluated to optimise and test
the effect of a prolonged treatment phase. 
Besides these limitations, the data of the pres-
ent investigation underline that the programme
BASEL is an effective treatment procedure for
clinical practice, as demonstrated during the one
year follow-up. A reasonable weight loss was
achieved, and further changes in important eating
behaviour characteristics, such as increase in cog-
nitive control and decrease of distractibility were
initiated. Additionally, the acceptance of the own
body was improved. These results are of special
relevance because it is generally accepted that
these changes are predictive for long-term weight
loss and changes of lifestyle. 
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